Applied Dna Sciences, Inc. (QB) (USOTC:APDN)
Historical Stock Chart
1 Year : From Apr 2013 to Apr 2014
Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, anti-theft and product authentication solutions, today announced that its ongoing staff expansion has so far resulted in a 72% increase in scientific, quality, operational and other employees since January of the current year. The company now counts forty-eight staff in Stony Brook, NY, United Kingdom, and elsewhere. The expansion accommodates the company's worldwide growth, including a broader product array, and a growing sales pipeline. A more robust and larger plant is in place to support the expansion.
Company officials pointed to increasing number of contracts with suppliers of military electronics, a total of sixteen as of today, and calls for anti-theft assets, including those acquired from United Kingdom-based RedWeb Technologies, as examples of the increased demand.
"The addition of top-notch people and an improved facility are two keys to handling growth," said Dr. James A. Hayward, CEO and President of Applied DNA Sciences. "Our grow-the-company initiative will keep us steadily on the edge of science and innovation, something our customers have come to expect from us. We are prepared to deliver."
Dr. Hayward described the company's Technology Roadmap, which envisions a faster and higher-volume SigNature DNA marking platform, highly optimized rapid read, new breakthroughs in textile marking and authentication, and other forward steps in technology.
The company is currently moving into a new, 30,000 square foot building, with significantly larger and differentiated laboratory space, improved security arrangements, new staging, shipping and fulfillment centers, and an expanded front office.
"We will remain light on our feet and able to serve customers quickly and with precision," Dr. Hayward commented. "Our new infrastructure is built to empower that philosophy."
About Applied DNA Sciences
APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
Web site: http://www.adnas.com
Twitter: @APDN, @APDNInvestor.